Blood
WBC: 2,5X 10 9 /l HB: 11,3g/dl Platelets: 278.000X 10 9 /l Blasts: 0% Bone marrow: 56% (Hypocellular bone marrow, the number of blasts increased up to 56%. Blasts had round shape with a rounded nucleus and looped chromatin structure, with large blue nucleoli. The cytoplasm of blasts was blue and narrow without granularity. Part of the blasts had irregular shape with a bean-shaped nucleus and bright large nucleolus. Their cytoplasm was moderate or abundant, gray-blue with small azurophilic granules. Myelopoiesis: myeloid dysplasia, some cells have giant nuclei, scanty specific granularity, dissociation in the maturation of the nucleus and cytoplasm. Granulocytic population comprised approximately 26% of bone marrow cells. Erythropoiesis was represented by normoblasts. Megakaryocytopoiesis was decreased with hypolobular megakaryocytes). 
Cyto-Pathology Classification

Other molecular cytogenetics results
The semi-cryptic translocation t(7;21) was revealed in all metaphases and split of the RUNX1 gene was detected in the interphase nuclei (three red signals). 46,XY,t(7;21)(p22;q22) [20] .ish t(7;21)(RUNX1+;RUNX1+) [20] .
Other Molecular Studies
Technics: ASO-PCR, RFLP.
Results:
Mutations in NPM1 and FLT3 genes (ITD&D835) were not detected.
G-banded and partial mFISH karyograms showing t(7;21).
Interphase FISH with three signals of RUNX1 (red) and two signals of ETV6 (green) genes.
FISH with LSI ETV6/RUNX1 probe showing the red signals of RUNX1 on der(7) chromosome, der(21) chromosome and on normal chromosome 21. Two normal signals (green) of ETV6 are seen on the chromosomes 12.
Comments
Here, we report a new case of AML M4 with semicryptic t(7;21)(p22;q22). As known the translocation t(7;21)(p22;q22) is a rare recurrent abnormality in MDS and AML that results in a RUNX1-USP42 fusion as described previously (Paulsson et al., 2006) . Although all four patients with t(7;21) revealed a similar cytogenetic lesion, they varied in their clinicopathological features: of the three adults, the first one presented with RAEB-2, the second AML M5, the third AML M0 and the 7-year-old child had AML M0 too. All adults had chemosensitive disease, whereas the child had refractory AML following initial induction therapy and relapsed following allogeneic bone marrow transplantation. Current case of 13-year-old boy diagnosed with acute myelomonocytic leukemia also had evidence of persistent AML after initial course of treatment; he achieved complete hematological and cytogenetic remissions after FLAG. 
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